Back to results
RecruitingPhase 2

Radiotherapy Followed by Chemotherapy Combined With Toripalimab in Local Advanced HR-positive,HER2-negative BC.

NCT06705127

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

the First Affiliated Hospital，Zhejiang University School of Medicine

Hangzhou, Zhejiang, China

View on ClinicalTrials.gov
Radiotherapy Followed by Chemotherapy Combined With Toripalimab in Local Advanced HR-positive,HER2-negative BC. — TrialFind